Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare will revise labeling for two of its analgesic products to include more explicit warnings following FDA approval on Aug. 30
You may also be interested in...
FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign
FDA is "very seriously" looking into labeling changes for OTC pain relievers, according to outgoing Associate Commissioner for External Relations Peter Pitts
Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning
Warnings detailing the risk of gastrointestinal bleeding with use of aspirin and other non-steroidal anti-inflammatory drugs should replace the current alcohol warning on such products, NDAC members asserted during a meeting in Silver Spring, Md. Sept. 20
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC